natco pharma : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "natco pharma"

The Nifty Pharma Index is down 27% over the past year amid pricing and regulatory pressure

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%

The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy

In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, Author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?

Despite the strong industry headwind, Torrent Pharma remains in the pink of health, thanks to its diversified geographical presence and specialty products

Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs

With a powerful client base and an all-in-one package, the contract R&D firm Syngene is galloping ahead and now even into manufacturing 

Edelweiss Securities' head of research sees huge potential in Dr Reddy's, and also an attractive valuation 

Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market

OTT players are splurging on 'Originals' to stay ahead

By riding business and earning cycles, Invesco’s Amit Ganatra’s stock bets have paid rich dividend

As the market tumbles, mutual fund managers recommend pharma, private banks and specialty chemicals to tide over the volatility

The pharma industry has to deal with poor road connectivity and an unskilled labour force in Sikkim, but it seems to have made peace with the mountains

Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers

Laurus Lab founder Satyanarayana Chava increases stake as the stock loses steam post its weak show in Q4FY18

Dr Reddy’s promoter GV Prasad buys in the open market amid growing headwind

The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US

By focusing on its strength in manufacturing lyophilized injectables, Gufic Biosciences has made a strong comeback and wants to aggressively push into the EU market next

When change sets in, companies initially live in denial, and when it catches up, it’s too late

Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off